pd168393 has been researched along with Dermatitis, Atopic in 1 studies
PD 168393 : A member of the class of quinazolines carrying bromoanilino and acrylamido substituents at positions 4 and 6 respectively.
Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sääf, A | 1 |
| Pivarcsi, A | 1 |
| Winge, MC | 1 |
| Wahlgren, CF | 1 |
| Homey, B | 1 |
| Nordenskjöld, M | 1 |
| Tengvall-Linder, M | 1 |
| Bradley, M | 1 |
1 other study available for pd168393 and Dermatitis, Atopic
| Article | Year |
|---|---|
Characterization of EGFR and ErbB2 expression in atopic dermatitis patients.
Topics: Adolescent; Adult; Cell Differentiation; Cell Line; Chemokine CCL26; Chemokines, CC; Dermatitis, Ato | 2012 |